JOINN LABORATORIES(CHINA)CO.,LTD. Joinn Laboratories(China)Co.,Ltd. Share Price
Equities
603127
CNE100002W27
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.37 CNY | +2.72% |
|
+3.52% | -26.74% |
| Sales 2024 * | 2.41B 332M 26.63B | Sales 2025 * | 2.88B 398M 31.87B | Capitalization | 12B 1.66B 133B |
|---|---|---|---|---|---|
| Net income 2024 * | 514M 70.94M 5.68B | Net income 2025 * | 673M 92.88M 7.44B | EV / Sales 2024 * | 3.6 x |
| Net cash position 2024 * | 3.32B 458M 36.72B | Net cash position 2025 * | 3.68B 507M 40.63B | EV / Sales 2025 * | 2.89 x |
| P/E ratio 2024 * |
25.3
x | P/E ratio 2025 * |
19.4
x | Employees | 2,510 |
| Yield 2024 * |
0.97% | Yield 2025 * |
1.15% | Free-Float | 58.77% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +2.72% | ||
| 1 week | +3.52% | ||
| Current month | -3.93% | ||
| 1 month | -5.34% | ||
| 3 months | -4.46% | ||
| 6 months | -29.82% | ||
| Current year | -26.74% |
1 week
16.44
18.10
1 month
16.4419.40
Current year
13.8023.73
1 year
13.8036.34
3 years
13.8092.87
5 years
10.6792.87
10 years
2.3992.87
| Managers | Title | Age | Since |
|---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 42 | 31/10/12 |
Ai Shui Yu
DFI | Director of Finance/CFO | 48 | 30/06/19 |
Ye Li
CHM | Chairman | 42 | 31/12/06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yu Xia Feng
FOU | Founder | 60 | 10/08/95 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 30/11/96 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 30/09/99 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.46% | 2 M€ | -16.59% | - | |
| 0.03% | 2 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 17.37 | +2.72% | 18,670,250 |
| 25/04/24 | 16.91 | -0.82% | 11,812,820 |
| 24/04/24 | 17.05 | -2.57% | 13,013,380 |
| 23/04/24 | 17.5 | +3.12% | 16,251,100 |
| 22/04/24 | 16.97 | +1.13% | 9,044,722 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
Calendar
28/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
17.37
CNY
Average target price
19.29
CNY
Spread / Average Target
+11.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.74% | 1.66B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 603127 Stock
